31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
New York Governor Andrew Cuomo has signed into law a bill which, effective immediately, prohibits em...
Read More >
California Gov. Gavin Newsom signed Assembly Bill (AB) 5 into law on Sept. 18, 2019, codifying the s...
Read More >
The US Court of Appeals for the Sixth Circuit vacated the district court’s dismissal of trademark a...
Read More >
2018 saw the enactment of important changes to CASPA, a Pennsylvania law that helps contractors and ...
Read More >
Approximately four years ago, during the Obama Administration, the National Labor Relations Board up...
Read More >
The 2019 Private Target Mergers & Acquisitions Deal Points Study was recently released by the Busine...
Read More >